Почетна › Dijabetes tipa 2 › Вашингтон
Kliničke studije za Dijabetes tipa 2 u državi Вашингтон
23 studija za Dijabetes tipa 2 traži učesnike na lokacijama u državi Вашингтон.
Gradovi u državi Вашингтон
Zvanični tekst studije (na engleskom)
Evaluation of MiniMed Next Generation Extended Wear Sensors and Algorithm in Patients With Type 1 and Type 2 Diabetes
- Rainier Clinical Research Center, Renton
- Seattle Children's, Seattle
Тражи се учесник
Узраст од 2 до 80 · Оба пола · Ажурирано 13. 11. 2026. · NCT07864168A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
- ERA Health Research - Redmond, Redmond
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 13. 11. 2026. · NCT07754461EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Universal Research Group, LLC, Tacoma
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT07064473A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Era Health Research, Redmond
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT07351058Maridebart Cafraglutide Versus Semaglutide in Participants With Type 2 Diabetes
- Eastside Research Associates Health Research, Redmond
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07866066A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes
- Eastside Research Associates, Redmond
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07881458A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
- Eastside Research Associates, Redmond
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 4. 11. 2026. · NCT06897475A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
- Research Site, Redmond
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 30. 10. 2026. · NCT07662109Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
- Providence Medical Research Center, Spokane
Тражи се учесникФаза 2
Узраст од 18 до 80 · Оба пола · Ажурирано 27. 10. 2026. · NCT07271186A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
- Research Site, Renton
- Research Site, Seattle
- Research Site, Seattle
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 22. 10. 2026. · NCT07662213A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
- Seattle Children's Research Institute, Seattle
Тражи се учесникФаза 3
Узраст од 10 до 18 · Оба пола · Ажурирано 19. 10. 2026. · NCT07282613A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
- The Vancouver Clinic, Vancouver
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 7. 10. 2026. · NCT07668388A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
- Providence Regional Medical Center Everett, Everett
- University of Washington, Seattle
Тражи се учесникЗдраве особе су добродошле
Узраст 55 и старији · Оба пола · Ажурирано 28. 9. 2026. · NCT06112418Sleep Loss and Circadian Misalignment - Mechanisms of Insulin Resistance
- Sleep and Performance Research Center, Spokane
Тражи се учесникФаза 4Здраве особе су добродошле
Узраст од 18 до 45 · Оба пола · Ажурирано 18. 9. 2026. · NCT07494084A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Seattle
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 16. 9. 2026. · NCT07743450A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
- Research Site, Renton
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 31. 8. 2026. · NCT07662044A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies
- Research Site, Renton
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 25. 8. 2026. · NCT07606066A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
- Seattle Children's Hospital, Seattle
Тражи се учесникФаза 3
Узраст од 10 до 17 · Оба пола · Ажурирано 7. 8. 2026. · NCT06739122A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin
- Research Site, Renton
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 4. 8. 2026. · NCT07664553ROME GS System Study
- Rainier Clinical Research Center, Renton
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 21. 4. 2026. · NCT07518004Effects of High-Resistance Inspiratory Muscle Strength Training on Cardiorenal and Vascular Function in Youth and Young Adults With Type 2 Diabetes
- Seattle Children's Hospital, Seattle
- University of Washington Medicine Diabetes Institute, Seattle
Тражи се учесник
Узраст од 14 до 40 · Оба пола · Ажурирано 13. 6. 2025. · NCT06936670Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study)
- Seattle Children's Hospital, Seattle
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
Узраст од 8 до 14 · Оба пола · Ажурирано 24. 3. 2025. · NCT05008276Effects of Semaglutide on Intracranial Blood Flow and Brain-Barrier Permeability in Type-2 Diabetes
- University of Washington - Harborview Medical Center, Seattle
Тражи се учесникФаза 4
Узраст од 40 до 65 · Оба пола · Ажурирано 5. 6. 2024. · NCT05780905Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.